1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 11th November 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Trial Report Dysregulation of the autonomic nervous system in ME/CFS and post-COVID syndrome: insights from 48-h heart rate variability monitoring, 2023, Ziaja

Discussion in 'ME/CFS research' started by Dolphin, Jan 2, 2024.

  1. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    5,802
    https://www.jns-journal.com/article/S0022-510X(23)00702-5/fulltext

    ABSTRACT| VOLUME 455, SUPPLEMENT , 121241, DECEMBER 2023

    Dysregulation of the autonomic nervous system in ME/CFS and post-COVID syndrome: insights from 48-h heart rate variability monitoring
    DOI:https://doi.org/10.1016/j.jns.2023.121241





    Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-COVID Syndrome are post-viral syndromes that share similar symptoms and pathophysiological mechanisms. Dysregulation of the autonomic nervous system (ANS) and postural orthostatic tachycardia syndrome (POTS) have been found in both conditions. This study aimed to investigate possible ANS dysregulation and heart rate variability (HRV) in ME/CFS and Post-COVID Syndrome through continuous (48-h) monitoring.
     
    Dolphin, Jan 2, 2024
    #1
    DokaGirl, Michelle, oldtimer and 1 other person like this.
  2. Trish

    Trish Moderator Staff Member

    Messages:
    55,446
    Location:
    UK
    Posts about some other studies by the same researchers have been moved to new threads:

    Advancing Therapeutics for Post-Viral ME/CFS and SFN in Long COVID: A 20- Week Sensomotoric Training Intervention, 2023, Ziaja et al

    Comparing Fractional Anisotropy Diffusion Tensor Imaging of Patients with ME/CFS, Long COVID and Healthy Controls, 2023, Ziaja et al

    Advanced Imaging Analysis Reveals Altered Volume Segmentation, Structural Characteristics, and Fractional Anisotropy in ME/CFS and PCS, 2023, Ziaja et

    A 6-month Ibudilast treatment regimen aimed to improve brain function in ME/CFS patients: A case study, 2023, Ziaja et al
     
    Trish, Jan 2, 2024
    #2
    DokaGirl, Michelle, Dolphin and 1 other person like this.

Share This Page